加州再生医学研究所独立公民监督委员会定期会议治理小组委员会。 根据加利福尼亚州干细胞研究与治疗法案组织。 将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

Translational Candidate Genetically-corrected patient iPSC-derived neural progenitor cells, which have demonstrated efficacy to correct disease phenotype in a CD mouse model. Area of Impact This ...

The maximum total funding for a DISC4 Award is $13 million per award. The maximum award duration is four years. Applicant Core Teams must be multi-institutional and include at least five California ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Skeletal muscle stem and progenitor cells including those derived from human pluripotent stem cells (hPSCs) offer an avenue towards personalized therapies and readily fuse to form human-mouse ...

X-linked agammaglobulinemia (XLA) is a monogenic primary immune deficiency characterized by very low levels of immunoglobulins and greatly increased risks for recurrent and severe infections. Patients ...

We focus on type 1 diabetes in this proof-of-concept study, but the therapeutic platform the study will develop can be applied to many autoimmune indications and transplantation. Type 1 diabetes (T1D) ...

Priyanka Mishra, Anusha Sivakumar, Avalon Johnson, Carla Pernaci, Anna S Warden, Lilas Rony El-Hachem, Emily Hansen, Rafael A Badell-Grau, Veenita Khare, Gabriela Ramirez, Sydney Gillette, Angelyn B ...

Individualized genetic therapies-medicines that precisely target a genetic variant that may only be found in a small number of individuals, as few as only one-offer promise for addressing unmet needs ...

This DISC2 tests a strategy to target survival and self-renewal in glioma stem cells (GSC), and will identify a therapeutic candidate for safety, dosing and efficacy testing. Investigate C3a-C3aR ...